| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |